The group’s principle activity is to develop technology to improve pharmaceutical manufacturing. The group specializes in pharmaceuticals that are produced by fermentation, which encompasses a large range of products from antibiotics to anticancer agents, immunosuppressants, and many others types of natural products. The group also develops technology for co-product recovery. The group operates from United States.
